EVGN (Evogene) Purchase Of Investment : $-18.14 Mil (TTM As of Dec. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Evogene Purchase Of Investment?

Evogene's purchase of investment for the three months ended in Dec. 2024 was $-17.15 Mil. It means Evogene spent $17.15 Mil on purchasing investments. Evogene's purchase of investment for the trailing twelve months (TTM) ended in Dec. 2024 was $-18.14 Mil.

Compared with last quarter ($0.00 Mil in Sep. 2024 ), Evogene spent more money on purchasing investments in Dec. 2024 ($-17.15 Mil).

Evogene Purchase Of Investment Historical Data

The historical data trend for Evogene's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evogene Purchase Of Investment Chart

Evogene Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Purchase Of Investment

Get a 7-Day Free Trial

-24.11

-0.91

-19.70

-17.15

Evogene Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Purchase Of Investment	Get a 7-Day Free Trial															-	-4.23	3.24	-	-17.15

Evogene Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-18.14 Mil.

Evogene Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Evogene's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Evogene Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Evogene Ltd (NAS:EVGN) » Definitions » Purchase Of Investment

Comparable Companies

Traded in Other Exchanges

EVGN:Israel

Address

13 Gad Feinstein Street, Park Rehovot, Ness Ziona, Rehovot, ISR, 7638517

Website

https://www.evogene.com

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.